Thomas J. Rademaker

Thomas J. Rademaker

Auto-generated profile, based on publicly available information

Thomas J. Rademaker

Department of Physics, McGill University, Montreal, Quebec, Canada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2022 in Science
Verified
Journal Article
Closed access
SASooraj R. Achar
Sooraj R. Achar
FBFrançois X. P. Bourassa
François X. P. Bourassa
TRThomas J. Rademaker
Thomas J. Rademaker
ALAngela Lee
Angela Lee
TKTaisuke Kondo
Taisuke Kondo
GAGrégoire Altan-Bonnet
Grégoire Altan-Bonnet
Systems immunology lacks a framework with which to derive theoretical understanding from high-dimensional datasets. We combined a robotic platform with machine learning to experimentally measure and theoretically model CD8 + T cell activation. High-dimensional cytokine dynamics could be compressed onto a low-dimensional latent space in an antigen-specific manner (so-called “antigen encoding”). We used antigen encoding to model and reconstruct patterns of T cell immune activation. The model delineated six classes of antigens eliciting distinct T cell responses. We generalized antigen encoding to multiple immune settings, including drug perturbations and activation of chimeric antigen receptor T cells. Such universal antigen encoding for T cell activation may enable further modeling of immune responses and their rational manipulation to optimize immunotherapies.

1 November 2021 in Cell Reports
Verified
Journal Article
Open access
DRDakota Rogers
Dakota Rogers
ASAditi Sood
Aditi Sood
HWHanChen Wang
HanChen Wang
JBJasper J.P. van Beek
Jasper J.P. van Beek
TRThomas J. Rademaker
Thomas J. Rademaker
JMJudith Mandl
Judith Mandl
CD4+ T cells have a remarkable potential to differentiate into diverse effector lineages following activation. Here, we probe the heterogeneity present among naive CD4+ T cells before encountering their cognate antigen to ask whether their effector potential is modulated by pre-existing transcriptional and chromatin landscape differences. Single-cell RNA sequencing shows that key drivers of variability are genes involved in T cell receptor (TCR) signaling. Using CD5 expression as a readout of the strength of tonic TCR interactions with self-peptide MHC, and sorting on the ends of this self-reactivity spectrum, we find that pre-existing transcriptional differences among naive CD4+ T cells impact follicular helper T (TFH) cell versus non-TFH effector lineage choice. Moreover, our data implicate TCR signal strength during thymic development in establishing differences in naive CD4+ T cell chromatin landscapes that ultimately shape their effector potential.